about
SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobankingStem cell therapy for diabetes mellitusC-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitusImmunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusionInteraction between IL-6 and TNF-α genotypes associated with bacteremia in multiple myeloma patients submitted to autologous stem cell transplantation (ASCT).Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.Cellular immunotherapy after allogeneic stem cell transplantation in hematologic malignancies.Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients.Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis.Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patientsRisks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes.Different expression patterns of LGALS1 and LGALS3 in polycythemia vera, essential thrombocythemia and primary myelofibrosis.Acute myeloid leukemia: update in diagnosis and treatment in Brazil.Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantation.Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment.Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival.Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.Successful outcome of allogeneic stem cell transplantation in Seckel syndrome.Importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance.Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients.Autologous HSCT for systemic sclerosis - Authors' reply.Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.Use of therapeutic laser for prevention and treatment of oral mucositis.Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party.Large DNA inversions, deletions, and TaqI site mutations in severe haemophilia A.Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG.Molecular bases of the ABO blood groups of Indians from the Brazilian Amazon region.Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH report.Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis.Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation.Variation of resting energy expenditure after the first chemotherapy cycle in acute leukemia patients.Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.Reversine triggers mitotic catastrophe and apoptosis in K562 cells.Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.Haematological recovery in poor and good haematopoietic stem cell mobilisers.Apoptosis- and cell cycle-related genes methylation profile in myeloproliferative neoplasms.
P50
Q26853573-31AD9B03-363E-41CF-A68D-97C18E2F0A7FQ27011453-B10CDF64-CD02-4093-8BC8-91FF8F7EF57CQ28241260-7BD0B033-EC34-4A0B-9201-4196E520BC3DQ28296706-40AC90D7-CD48-4173-9FCD-FD90ACD862B7Q34436188-C0A6F9A7-3FCB-45D0-B340-915A0F6F5D3BQ35181927-E0A79680-06B0-4126-9650-11E0DD29E0EDQ35742787-8D848EA0-A178-4011-91E5-9B513B761264Q36125427-DAB1A341-7D47-42D2-8029-6866CC31C32FQ36901406-636D2F06-F033-41C7-9467-282730C9CE0DQ37089931-2CD4B1D1-98F8-4B61-AA4E-EF58A26B4C4DQ38032163-0967925F-B59C-4A87-BA1B-D178B7E31B86Q38758671-C0973AF2-CFD9-4791-AEB0-0DB9066A1906Q40114215-8DBD46E6-3ED9-440E-A1E8-D6D4EB52E1FAQ40237552-3AEC54BE-50D4-404E-954E-CA1485536D80Q40452463-400E47F6-6181-4BC0-9210-360D2E9D8888Q40581439-35271B8D-1782-4C5D-818B-D95457CCEDFCQ40758763-8FAB1D8A-7768-4875-B084-0A5D8281F0AAQ41196008-77B94D7D-FB0A-4F6F-B8C7-939567EF74F4Q41470558-6E2AA7A2-80F7-47C9-ABA3-DC4F1A150E2EQ41715953-1B1A68E0-7930-4537-9C4C-BD0819CCF41BQ41930725-D6C677FF-88DE-418F-9485-DE85DCF4A49DQ42409714-4B624BD8-FBF3-4058-B214-80F6AD475EE7Q44300500-BEB71F73-993A-41D9-8DF5-510FBB5440C1Q44501248-C802F399-661B-4044-B62C-86F64027AA04Q44582257-5E4791EE-D33D-439A-8EB2-D9A882E96CBEQ45103807-8F5E979E-C9C5-4510-B0F5-76E11E88AE77Q45867293-123D4325-3CCE-411E-A02E-1C2F81C5B593Q45871187-A2A76B23-5D95-40C2-8264-DA20BBD426B5Q45936271-BBB88677-59F3-4FE2-AEE7-1F8CCF385836Q46165345-4280A08F-784E-4722-8FAA-FB33D6B1918CQ46314561-3D91AD0F-B164-489A-B088-6CAD2B54DE8FQ46902509-CDDA321C-00E9-4510-AA5A-B6970C784828Q48608172-10BF6E9E-15AE-45FF-95DC-598A5EA8ADDAQ50641737-B39C0FE8-D967-4BF0-A866-FEDCEFC0303EQ50747819-67E185FE-932D-4BE1-A4EC-5872F8FFC04EQ51350303-FBF4DFE7-AAF2-40E2-83F8-30E3554A5D8FQ51623731-5E122510-50EB-46F5-957E-2BBF201D0DCCQ52837423-19CB9F1B-1016-4A00-8BE5-1B848A433D6EQ52866895-1CAF2772-F602-4A2E-9B72-B9193B8F0698Q52912112-13D14539-3A7C-48BD-A68D-D4D669DEC2CF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Belinda Pinto Simoes
@ast
Belinda Pinto Simoes
@en
Belinda Pinto Simoes
@es
Belinda Pinto Simoes
@nl
type
label
Belinda Pinto Simoes
@ast
Belinda Pinto Simoes
@en
Belinda Pinto Simoes
@es
Belinda Pinto Simoes
@nl
prefLabel
Belinda Pinto Simoes
@ast
Belinda Pinto Simoes
@en
Belinda Pinto Simoes
@es
Belinda Pinto Simoes
@nl
P106
P21
P31
P496
0000-0003-4508-8934